

Company Type: Midmarket, Public
Industry: Biopharmaceutical
Solution Area: Interim Finance, Technical Accounting
A senior-level gap in the finance team kept opening up at a biopharmaceutical company with approximately $90 million in revenue and 300 employees. As the year-end approached without a cost accounting manager or director, they needed immediate support and input on what was best for the role going forward.
A pressing deadline and an opening in the finance team led to the need for interim cost accounting expertise. On the docket were year-end cost accounting activities, including:
The finance pro would have to find her own way, with only minimal documentation available for the current cost accounting process. As the cost accounting ace’s work was underway, the company was acquired, resulting in more turnover and changes in business operations, which had to be factored into inventory valuation, and shortened accounting deadlines.
“Mary has been instrumental in our success. She is versatile and adaptable and was able to quickly learn our processes and make meaningful suggestions for improvements.
Her breadth of experience was key to our being able to meet new reporting deadlines quickly. We could not have done this without her!”
- Corporate Controller
We are in the markets that matter, but we show up like we’re part of your team. Hands-on, high-touch, and built around your goals.